MedTrace Logo

Study of a Novel Microlens Array Device for Skin Rejuvenation

NCT02888626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-08-15

Study results available
· View outcomes & findings →

Summary

A single-center prospective, open-label uncontrolled pilot study. Subjects will receive laser treatments and will be followed at 12 weeks post-final treatment.

Conditions

  • Wrinkles
  • Scars

Interventions

DEVICE

Microlens Array

Treatment with Cutera Microlens Array Device used with the enlighten™ 532nm /1064nm/670nm laser

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, MD · P.I.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-02-06
Completion
2017-02-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888626 on ClinicalTrials.gov